RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared drug-delivery ...
Biomednewsbreaks Renovorx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...